PMV Pharmaceuticals Inc (NASDAQ: PMVP) kicked off on Tuesday, down -6.85% from the previous trading day, before settling in for the closing price of $1.46. Over the past 52 weeks, PMVP has traded in a range of $0.81-$1.84.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -14.06%. While this was happening, its average annual earnings per share was recorded -36.84%. With a float of $45.24 million, this company’s outstanding shares have now reached $52.99 million.
PMV Pharmaceuticals Inc (PMVP) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of PMV Pharmaceuticals Inc is 14.63%, while institutional ownership is 65.40%. The most recent insider transaction that took place on Sep 10 ’25, was worth 900,000. In this transaction 10% Owner of this company sold 500,000 shares at a rate of $1.80, taking the stock ownership to the 5,975,291 shares. Before that another transaction happened on Sep 10 ’25, when Company’s Shareholder proposed sale 2,283,654 for $1.60, making the entire transaction worth $3,653,846.
PMV Pharmaceuticals Inc (PMVP) Earnings and Forecasts
In the latest quarterly report, which was put into the public domain on 9/30/2024, the organization reported -0.37 earnings per share (EPS), lower than consensus estimate (set at -0.36) by -0.01. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.41 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -36.84% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -6.19% during the next five years compared to -14.06% drop over the previous five years of trading.
PMV Pharmaceuticals Inc (NASDAQ: PMVP) Trading Performance Indicators
Take a look at PMV Pharmaceuticals Inc’s (PMVP) current performance indicators. Last quarter, stock had a quick ratio of 12.52. For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -1.56, a number that is poised to hit -0.40 in the next quarter and is forecasted to reach -1.48 in one year’s time.
Technical Analysis of PMV Pharmaceuticals Inc (PMVP)
Compared to the last year’s volume of 0.5 million, its volume of 0.4 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 45.19%.
During the past 100 days, PMV Pharmaceuticals Inc’s (PMVP) raw stochastic average was set at 53.40%, which indicates a significant decrease from 53.85% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0885 in the past 14 days, which was lower than the 0.0959 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.4171, while its 200-day Moving Average is $1.2564. Nevertheless, the first resistance level for the watch stands at $1.4233 in the near term. At $1.4867, the stock is likely to face the second major resistance level. The third major resistance level sits at $1.5233. If the price goes on to break the first support level at $1.3233, it is likely to go to the next support level at $1.2867. Should the price break the second support level, the third support level stands at $1.2233.
PMV Pharmaceuticals Inc (NASDAQ: PMVP) Key Stats
The company with the Market Capitalisation of 72.07 million has total of 52,991K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -58,710 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -21,210 K.
